Today: October 02, 2024
Today: October 02, 2024

Latest From Reuters

Business|Health

Novo Nordisk reprimanded in UK for failure to disclose payments to healthcare sector

Danish drugmaker Novo Nordisk has been reprimanded by UK regulators for failing to disclose fees and expenses paid to individuals and organisations in Britain amounting to about

Novo Nordisk reprimanded in UK for failure to disclose payments to healthcare sector
Business|Economy|Health

AbbVie cuts 2024 profit forecast on R&D expenses

AbbVie lowered its 2024 adjusted profit forecast on Wednesday, citing $937 million in milestones, and research and development expenses related to acquisitions.

AbbVie cuts 2024 profit forecast on R&D expenses
Health

EU approves Sanofi's Dupixent for 'smoker's lungs'

Sanofi and partner Regeneron on Wednesday won European Union approval for wider use of their Dupixent injection in patients with a chronic lung disease, a rare case of the EU clearing a

EU approves Sanofi's Dupixent for 'smoker's lungs'
Health

Indonesia says it will regulate cultivation, export of herbal kratom products

Indonesia said on Thursday it would start regulating the cultivation and export of kratom, a substance that advocates say can help ease pain alongside other benefits, but is listed

Indonesia says it will regulate cultivation, export of herbal kratom products
Business|Health

Haleon to sell nicotine replacement therapy business outside US for $633 million

Haleon will sell its nicotine replacement therapy business outside the U.S. to a unit of India's Dr.

Haleon to sell nicotine replacement therapy business outside US for $633 million
Health

China approves AstraZeneca's Tagrisso-chemo combo as first-line treatment

China has approved the use of AstraZeneca's blockbuster cancer drug Tagrisso in combination with chemotherapy as a first line of treatment for adults with a type of advanced lung cancer,

China approves AstraZeneca's Tagrisso-chemo combo as first-line treatment
Business|Health

Blackstone selling Japan drugmaker Alinamin to MBK Partners

Blackstone and MBK Partners said on Wednesday the U.S. private equity firm is selling Japanese drugmaker Alinamin Pharmaceutical to the North Asian buyout fund.

Blackstone selling Japan drugmaker Alinamin to MBK Partners
Business|Health

Walmart has held talks to sell its shuttered medical clinics, Fortune reports

Walmart has held talks with potential buyers to sell its already shuttered medical clinics, Fortune reported on Tuesday, citing multiple sources familiar with the matter.

Walmart has held talks to sell its shuttered medical clinics, Fortune reports
Business|Health

US DOJ drops Viatris unit Mylan from industry-wide antitrust probe

Viatris unit Mylan is no longer a subject of the U.S.

US DOJ drops Viatris unit Mylan from industry-wide antitrust probe
Health

First drop in overdose deaths in 6 years, US preliminary data shows

The number of deaths from drug overdose fell 3% to 107,543 in 2023 from the previous year, according to preliminary data from the U.S.

First drop in overdose deaths in 6 years, US preliminary data shows
Education|Health

Lula visits convalescing Noam Chomsky in Sao Paulo

American linguist and philosopher Noam Chomsky, who is recovering in Brazil after he suffered a stroke last year, received a visit on Monday at his Sao Paulo home from Brazilian

Lula visits convalescing Noam Chomsky in Sao Paulo
Economy|Education|Health

World bank approves $700 million to boost Jordan's education, health and social care

The World Bank said on Monday that it had approved $700 million for two new programs aimed at strengthening Jordan's education, health and social assistance sectors.

World bank approves $700 million to boost Jordan's education, health and social care
Business|Health

South African pharmacy chain Clicks to sell drug maker after court ruling

South African pharmacy chain Clicks Group said on Monday it would sell drug maker Unicorn Pharmaceuticals to comply with a court ruling, clearing the way for the health ministry to issue

South African pharmacy chain Clicks to sell drug maker after court ruling
Business|Economy|Health

Sanofi eyes German insulin investment of up to $1.6 billion, source says

French drugmaker Sanofi is nearing a decision to invest between 1.3 billion and 1.5 billion euros ($1.4-$1.6 billion) to upgrade its production of long-acting insulin shots in

Sanofi eyes German insulin investment of up to $1.6 billion, source says
Health

AstraZeneca's COVID prevention drug application gets EU fast-track assessment

AstraZeneca said on Monday that the European Union drug regulator has accepted a market authorisation application for its investigational COVID-19 prevention drug, sipavibart, for an

AstraZeneca's COVID prevention drug application gets EU fast-track assessment
Business|Health

Boots chief quits after Walgreens' sale plan stalls

The boss of British health and beauty retailer Boots is quitting after U.S. owner Walgreens Boots Alliance's plans for a sale or stock market listing of the chain stalled, according to a

Boots chief quits after Walgreens' sale plan stalls
Health

US FDA approves Roche's drug for a chronic blood disorder

The U.S.

US FDA approves Roche's drug for a chronic blood disorder
Health

Teva launches generic version of Novo Nordisk's diabetes drug Victoza

Teva Pharmaceuticals said on Monday it had launched a generic version of Novo Nordisk's Victoza to treat patients with type 2 diabetes, making it the first generic GLP-1 drug in the United

Teva launches generic version of Novo Nordisk's diabetes drug Victoza
Health

EU regulator backs approval for ARS Pharma's nasal spray alternative to EpiPen

ARS Pharmaceuticals said on Friday the European Medicines Agency (EMA) has recommended the approval of its needle-free emergency treatment, EURneffy, for allergic

EU regulator backs approval for ARS Pharma's nasal spray alternative to EpiPen
Business|Health

Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar

Amylyx Pharmaceuticals has agreed to buy the rights to bankrupt drugmaker Eiger BioPharmaceuticals' experimental drug for low blood sugar in a $35.1 million deal, Eiger said in a filing on

Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Business|Health

Lilly files more lawsuits to curb sales of counterfeit Mounjaro

U.S. drugmaker Eli Lilly said on Thursday it was suing six more entities including medical spas and wellness centers for selling products claiming to contain tirzepatide, the active

Lilly files more lawsuits to curb sales of counterfeit Mounjaro
Health

US FDA puts Zentalis' cancer drug studies on partial hold after patient deaths

The U.S. health regulator has placed three studies of Zentalis Pharmaceuticals' cancer drug on partial clinical hold following the death of two trial participants, the company said on

US FDA puts Zentalis' cancer drug studies on partial hold after patient deaths
Health

German vaccine panel endorses Astra-Sanofi's RSV shot for infants

Germany's influential vaccine advisory panel said on Thursday all infants in the country should receive AstraZeneca and Sanofi's antibody therapy to protect them against the

German vaccine panel endorses Astra-Sanofi's RSV shot for infants
Business|Health

Sanofi-backed Formation Bio raises $372 million in late-stage funding round

AI-based drug developer Formation Bio said on Wednesday that it has raised $372 million in a late-stage funding round, with a significant participation from French drugmaker Sanofi.

Sanofi-backed Formation Bio raises $372 million in late-stage funding round
Business|Economy|Health

Teva settles tax dispute in Israel with $750 million payment

Teva Pharmaceutical Industries has entered into a deal with the Israel Tax Authority to resolve all pending litigation related to taxes payable for the years from 2008 to 2020, the

Teva settles tax dispute in Israel with $750 million payment

Follow